Peptable

Comparison

Selank vs SS-31

Also see:

SelankSS-31

Function

While Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39, SS-31 improves mitochondrial bioenergetics, reduces oxidative stress, and shows protective effects in models of ischemia-reperfusion, neurodegeneration, and other mitochondrial disorders4637137.

Mechanism

While Selank works as a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39, SS-31 is a mitochondria-targeted tetrapeptide, d-Arg-dimethylTyr-Lys-Phe-NH2, that selectively binds cardiolipin in the inner mitochondrial membrane, stabilizing cristae structure, improving electron transport, and reducing ROS production4637137143.

Receptor

Selank

Not clearly established in the current dataset.

SS-31

Cardiolipin-rich inner mitochondrial membrane; interacts with cardiolipin and associated mitochondrial proteins rather than a classical cell-surface receptor46137143

Organism or Origin

Selank

Synthetic analog of the IgG-derived tetrapeptide tuftsin39

SS-31

Fully synthetic Szeto–Schiller tetrapeptide; not encoded in the genome4637

Gene

Selank

Not assigned in the current dataset.

SS-31

Not assigned in the current dataset.

Summary

The clearest overlap between Selank and SS-31 is that both converge around Signaling modulator. Their typical research and application settings separate fairly clearly: Selank is more often discussed in the realm of Neurology and brain health and Immunology and inflammation, whereas SS-31 is more often associated with the realm of Aging and longevity and Cardiovascular health. Both appear to work through Signaling modulator, but the functional emphasis still separates, with Selank leaning toward Anxiolytic and sleep modulation and Immune regulation and SS-31 leaning toward Mitochondrial function modulation, Antioxidant activity, and Neuroprotection and cognition. Selank has a more synthetic analog origin, while SS-31 is closer to synthetic design background with Selank approved for Research use only and SS-31 in Clinical phase 2. SS-31 incorporates d-amino acid substitution and amidation features that are not part of Selank, while their sequence patterns also diverge, with Selank showing proline-rich features and SS-31 showing cationic amphipathic features.

Related articles

No related articles are linked to these peptides yet.

Sources

39Application of thr-lys-pro-arg-pro-gly-pro peptide (selank) for ..., https://patents.google.com/patent/RU2629832C1/en
46Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2 ... - PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC11409442/
56Discovery of novel SS-31 (d-Arg-dimethylTyr-Lys-Phe-NH2 ..., https://pubs.rsc.org/en/content/articlelanding/2024/ra/d4ra05517a
137Mitochondrial protein interaction landscape of SS-31 | PNAS, https://www.pnas.org/doi/10.1073/pnas.2002250117
143SS-31 Peptide: Mitochondrial Repair for Energy and Longevity, https://revolutionhealth.org/blogs/news/peptide-therapy-ss-31